Other HEI awards provide for the purchase of four high-resolution mass spectrometers that allow access to the newest analytical techniques to advance the knowledge of human diseases; two supercomputers that rapidly process vast quantities of data; two cyclotrons for producing new probes for noninvasive imaging at the molecular level; and many other types of specialized equipment.
To qualify for a HEI award, institutions must identify three or more NIH-funded investigators whose research requires the requested instrument. These grants provide a maximum of $2 million each. Institutions are expected to provide an appropriate level of support for associated infrastructure, such as building alterations or renovations, technical personnel, and post-award service contracts for instrument maintenance and operation.

Ad Statistics
Times Displayed: 19605
Times Visited: 366 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
For more details on the 2008 HEI awardees, visit www.ncrr.nih.gov/hei_2008.
More information about the HEI program, including eligibility requirements and application guidelines, is available at: www.ncrr.nih.gov/hei.
NCRR, a part of NIH, provides laboratory scientists and clinical researchers with the resources and training they need to understand, detect, treat and prevent a wide range of diseases. NCRR supports all aspects of translational and clinical research, connecting researchers, patients, and communities across the nation. For more information, visit www.ncrr.nih.gov.
The National Institutes of Health (NIH) - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases.
For more information about NIH and its programs, visit www.nih.gov.
Back to HCB News